| B2 | Development and external validation of a prognostic model for survival of people living with HIV/AIDS initiating antiretroviral therapy | E-poster | Morbidity, mortality and life expectancy |
| D83 | Developing a cognitive dysfunction risk score for people who inject drugs in drug treatment | E-poster | People who use drugs (including by injection) |
| D12 | Determinants of recent HIVST uptake among Jiangsu MSM: a cross-sectional survey | E-poster | Uptake of HIV testing |
| C16 | Determinants of long-term HIV infections at point of HIV diagnosis in the Kingdom of Eswatini: results from the HIV-1 recent infection surveillance program | E-poster | Novel methods/algorithms for detecting acute and recent HIV infections |
| C39 | Determinants of HIV-free survival in the era of lifelong universal antiretroviral therapy (ART): pooled analysis of PEAWIL and IMPROVE studies, Lesotho | E-poster | PMTCT, including services for vulnerable populations |
| D6 | Designing tailored and scalable HIV and contraceptive services for adolescents in Gauteng, South Africa: translating discrete choice experiment results to cost-effectiveness results | E-poster | Demand creation for HIV services |
| D8 | Designing a peer-led comprehensive HIV program for transgender people in Bayelsa State, Nigeria: Early lessons from EpiC Nigeria | E-poster | Community-led initiatives |
| D97 | Depressive symptoms and heavy alcohol use predict transmission risk behaviors among new oral PrEP clients in Kenya: results from a prospective cohort study | E-poster | Pre-exposure prophylaxis |
| D66 | Depressive symptoms and ART adherence among women late in pregnancy who are living with HIV in Durban, South Africa | E-poster | Sexual and reproductive health, fertility, family planning, pregnancy, and abortion |
| B30 | Depression, anxiety, and polysubstance use among persons with HIV: baseline findings from the Promoting Access to Care Engagement (PACE) trial | E-poster | Substance abuse (including opioid use disorder) |